Belle Mead, NJ, United States of America

Yi-Lan Wang

This inventor holds 24 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 18 EPO patents, primarily in Hemostatic Materials. Top assignees: Ethicon, Gmbh, Ethicon Endo-Surgery, Inc., Cilag International Gmbh. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yi-Lan Wang. Retrieved from https://idiyas.com/inventor/yi-lan-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 2)

% Patents Active = 87.5

CIPO Patents = 5 (Patent Applications = 3)

EPO Patents = 18 (Patent Applications = 23)

Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 4,820(Granted Patents)

Location History:

Bell Mead, NJ (US) (2014)
Belle Mead, NJ (US) (2014 - 2019)
Somerset, NJ (US) (2017 - 2024)

Company Filing History:

Ethicon Endo-Surgery, Inc.

patents

3 out of 2,575

Cilag International Gmbh

patents

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Hemostatic Tablets

Oxidized Regenerated Cellulose

Surgical Staple Assembly

Procoagulant Peptides

Hemostatic Paste

Multi-Compartment Syringes

Hemostatic Composite

Cellulosic Aggregates

Sealant Dressing

Fibrin Pad Matrix

Galvanic Particulates

Surface Enrichment

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12734268 - Expandable hemostatic tablets comprising oxidized regenerated cellulose (2026-09-15),

2. 12377185 - Sealant dressing with protected reactive components (2025-08-05),

3. 12364785 - Expandable hemostat composed of oxidized cellulose (2025-07-22),

4. 12285540 - Hemostatic composite aggregate materials having surface enriched with hemostatis-promoting agents (2025-04-29),

5. 12201743 - Compacted hemostatic cellulosic aggregates (2025-01-21),

6. 11896732 - Compacted hemostatic cellulosic aggregates (2024-02-13),

7. 11883554 - Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery (2024-01-30),

8. 11235085 - Compacted hemostatic cellulosic aggregates (2022-02-01),

9. 11007299 - Hemostatic paste having surface enriched with hemostasis-promoting agents and devices for delivery (2021-05-18),

10. 10456526 - Multi-compartment pre-filled mixing syringes with bypass (2019-10-29),

11. 10183132 - Methods and devices for co-delivery of liquid and powdered hemostats and sealants (2019-01-22),

12. 10034957 - Compacted hemostatic cellulosic aggregates (2018-07-31),

13. 10022411 - Hemostatic preparation containing an extract of golden moss (2018-07-17),

14. 10022410 - Hemostatic preparation containing an extract of golden moss (2018-07-17),

15. 9731076 - Multi-compartment pre-filled mixing syringes with bypass (2017-08-15),

Title: The Innovative Journey of Yi-Lan Wang

Introduction: Yi-Lan Wang, a pioneering inventor based in Belle Mead, NJ, is known for her groundbreaking contributions to various fields through her inventive spirit and dedication to innovation.

Latest Patents: Wang's latest patents include advancements in renewable energy technologies, sustainable materials, and medical devices, showcasing her versatility and commitment to creating a positive impact on society.

Career Highlights: With a career spanning over two decades, Wang has established herself as a prominent figure in the world of innovation, holding numerous patents and receiving recognition for her innovative solutions to complex challenges.

Collaborations: Throughout her career, Wang has collaborated with leading research institutions, universities, and companies to further develop and commercialize her inventions, demonstrating her ability to work effectively in multidisciplinary teams.

Conclusion: Yi-Lan Wang's relentless pursuit of innovation and her passion for creating solutions that improve lives make her a true trailblazer in the world of inventors, inspiring future generations to push the boundaries of what is possible.

Profile summary based on public USPTO records.